|
Monday, 08/02/2010
|
The Zero-Truncated Poisson Model with Right Censoring: An Application to Translational Breast Cancer Research
Hung-Wen Yeh, The University of Kansas Medical Center; Purna Mukhopadhyay, The University of Kansas Medical Center; Fariba Behbod, The University of Kansas Medical Center; Byron J. Gajewski, The University of Kansas
8:50 AM
|
A Case Study of Using a Genomic Assay to Predict the Benefit of Chemotherapy in Treating Breast Cancer: Testing, Prediction, and Study Planning
William E. Barlow, Cancer Research and Biostatistics (CRAB); Carl Yoshizawa, Genomic Health, Inc.
11:00 AM
|
A Bayesian Model for Misclassified Binary Outcomes and Correlated Survival Data, with Applications to Breast Cancer
Min Yi, The University of Texas Health Science Center at Houston; Sheng Luo, The University of Texas School of Public Health; Xuelin Huang, MD Anderson Cancer Center; Kelly K. Hunt, MD Anderson Cancer Center
11:15 AM
|
A Bayesian Shrinkage Model for Incomplete Longitudinal Binary Data with Application to the Breast Cancer Prevention Trial
Chenguang Wang, FDA; Michael J. Daniels, University of Florida; Daniel O. Scharfstein, Johns Hopkins Bloomberg School of Public Health; Stephanie R. Land, University of Pittsburgh
11:35 AM
|
|
Tuesday, 08/03/2010
|
High Dimentional ROC Analysis Can Improve the Correlation Between Histological Grade (HG) and Oncotype-Dx (ONC) Recurrence Risk (RR) in Breast Cancer (BC)
Yufeng Li, The University of Alabama at Birmingham; Choo Hyung Lee, The University of Alabama at Birmingham; Omar Hameed, The University of Alabama at Birmingham
|
Discovering Influential Variables: A Partition-Based Learning Method to Identify Susceptible Genetic Risk Factors in Common Human Disorders
Tian Zheng, Columbia University; Herman Chernoff, Harvard University; Shaw-Hwa Lo, Columbia University
8:35 AM
|
Estimating Reduction in Absolute Breast Cancer Risk in Individuals and Populations from Modifying Risk Factors
Elisabetta Petracci, Institute of Medical Statistics and Biometry ; Adriano Decarli, Institute of Medical Statistics and Biometry ; Domenico Palli, Scientific Institute of Tuscany; Giovanna Masala, Scientific Institute of Tuscany; David Pee, Information Management Service Inc.; Ruth Pfeiffer, National Cancer Institute; Catherine Schairer, Division of Cancer Epidemiology and Genetics; Mitchell H. Gail, National Cancer Institute
8:50 AM
|
An Assessment of Quality of Life Among Breast Cancer Survivors in Punjab Using Ordinal Regression
Shahid Kamal, University of the Punjab; Ghausia Masood Gilani, University of the Punjab; Rehan Ahmad Khan, University of the Punjab; Afza Rasul, University of the Punjab
9:20 AM
|
I-SPY2: Identifying Biomarker Signatures for Therapeutic Agents in Neoadjuvant Breast Cancer
Donald Arthur Berry, MD Anderson Cancer Center; Kyle Wathen, MD Anderson Cancer Center; Nebiyou Bekele, MD Anderson Cancer Center; Laura Esserman, University of California, San Francisco
11:35 AM
|
|